Journal Club
February 2022: Dolutegravir as First- or Second-line Treatment for HIV-1 Infection in Children
Article and Study Summary: Dolutegravir as First- or Second-line Treatment for HIV-1 Infection in Children Published in: New England Journal of Medicine 2021,385(27):2531-2543. https://www.nejm.org/doi/full/10.1056/NEJMoa2108793 Authors: Turkova A, White E, Mujuru HA,...
January 2022: Multicomponent Strategy with Decentralized Molecular Testing for Tuberculosis
Article and Study Summary: Multicomponent Strategy with Decentralized Molecular Testing for Tuberculosis. Published in: New England Journal of Medicine. 2021;385(26):2441-2450 https://www.nejm.org/doi/full/10.1056/NEJMoa2105470 Authors: Cattamanchi A, Reza TF,...
November/December 2021: Treating Depression and Improving Adherence in HIV Care with Task-Shared Cognitive Behavioural Therapy in Khayelitsha, South Africa: A Randomized Controlled Trial
Article and Study Summary: Treating Depression and Improving Adherence in HIV Care with Task-Shared Cognitive Behavioural Therapy in Khayelitsha, South Africa: A Randomized Controlled Trial Published in: Journal of the International AIDS Society 2021, 24:e25823....
